A research study within the US Military Health System deploys Clinical ink’s platform among those with and without COVID-19 to understand long COVID Horsham, PA […]
Oxford NeuroMetrology Group Successfully Deploys Clinical ink Mobile Platform to Monitor Parkinson’s Patients at Home Horsham, Pa.; August 11, 2022 — Clinical ink, a global
85% accuracy in early Parkinson’s classification establishes Clinical ink as the industry leader in patient science and digital biomarkers.
Cutting-edge research reveals greater insights into Parkinson’s Disease progression Read More...
JAMA publication demonstrates assessment validity, points to future research and real-world applications Horsham, Pa.; February 16, 2022 — Clinical ink, a global clinical technology company,
Clinical ink’s technology deployed for groundbreaking cannabis research Read More...
Discover how Clinical ink is advancing Alzheimer’s research by supporting 16th concurrent clinical trials in 25 countries, involving over 9,000 patients.
Horsham, Pa.; June 2, 2020 – Clinical Ink, a global clinical trial technology company, has helped expedite the study of a treatment for cytokine storm,
Sales and Solutions
Direct 1.336.464.0697
Support
Toll-Free 1.800.301.5033
Direct 1.336.464.0697
Insert HTML text here.
Request more information, submit questions, set up a demonstration, and more.
